Disinfectants: The role of standardised testing to aid selection. Part 2

2019 ◽  
Vol 20 (3) ◽  
pp. 116-121
Author(s):  
Martyn AC Wilkinson ◽  
Evonne T Curran ◽  
Christina R Bradley

Choosing which disinfectant(s) to use in any particular healthcare environment is a far from trivial task and one that is undertaken by Infection Prevention and Control (IPC) professionals on a regular basis. The recent proliferation in the number and type of products designed to disinfect healthcare surfaces makes for a seemingly bewildering range of options. The primary factor to consider is whether the disinfectant is capable of killing the likely (but unknown) microbial challenge. For reusable non-invasive care equipment, standardised testing provides objective evidence for IPC teams. This second paper seeks to explain these tests and the conditions under which they are performed to aid in the IPC teams’ disinfection selection.

2001 ◽  
Vol 22 (7) ◽  
pp. 459-463 ◽  
Author(s):  
Andrew E. Simor

AbstractHospital infection prevention and control programs rely extensively on diagnostic microbiology laboratory testing. However, specimens for microbiological evaluation are less likely to be obtained from elderly residents of long-term–care facilities (LTCFs). In this article, issues regarding laboratory utilization and the potential role of the microbiology laboratory in infection prevention and control programs in LTCFs are reviewed. The role of the laboratory in infection surveillance, in the management of antimicrobial resistance, and in outbreak investigation are highlighted.


Author(s):  
Jarapla Srinivas Nayak ◽  
Tittu Thomas James ◽  
Shubham Menaria ◽  
Dr. Centina Rose John ◽  
Dr. Dhargave Pradnya

COVID-19 is a new pandemic disease which was reported initially at the city of Wuhan in the Hubei province ofChina on 31 December 2019. 1Recent events have reported its presence in more than 150 countries and with 132758 confirmed cases and a total of 4955 deaths as on 13th March 2020.2Although the death rate due to the disease is 6% or less, the persons who are affected in a short span of time is at an alarming rate.3 In this context, World Health Organization (WHO) have declared the disease as pandemic on 11th March 2020.


2020 ◽  
Vol 53 (1) ◽  
pp. 43-55
Author(s):  
William Marty Martin ◽  
Yvette Lopez ◽  
Thomas P. Flannery ◽  
Bill Dixon

Infectious diseases at work can be endemic such as seasonal influenza and emerging such as the novel coronavirus 2019. Infectious diseases have an impact on employees and other types of workers. Compensation and benefits professionals are often at the forefront of preventing workplace infections, addressing workplace infections, and ensuring the continuity of talent when workplace outbreaks and business shutdowns occur. This article provides an overview of pertinent laws, key compensation decisions, and ways to refocus existing benefit programs to meet the challenge of not only just safety, health, and wellness but also infection prevention and control.


Author(s):  
Sara Tomczyk ◽  
Julie Storr ◽  
Claire Kilpatrick ◽  
Benedetta Allegranzi

Abstract Background The coronavirus disease-2019 (COVID-19) pandemic has again demonstrated the critical role of effective infection prevention and control (IPC) implementation to combat infectious disease threats. Standards such as the World Health Organization (WHO) IPC minimum requirements offer a basis, but robust evidence on effective IPC implementation strategies in low-resource settings remains limited. We aimed to qualitatively assess IPC implementation themes in these settings. Methods Semi-structured interviews were conducted with IPC experts from low-resource settings, guided by a standardised questionnaire. Applying a qualitative inductive thematic analysis, IPC implementation examples from interview transcripts were coded, collated into sub-themes, grouped again into broad themes, and finally reviewed to ensure validity. Sub-themes appearing ≥ 3 times in data were highlighted as frequent IPC implementation themes and all findings were summarised descriptively. Results Interviews were conducted with IPC experts from 29 countries in six WHO regions. Frequent IPC implementation themes including the related critical actions to achieve the WHO IPC core components included: (1) To develop IPC programmes: continuous advocacy with leadership, initial external technical assistance, stepwise approach to build resources, use of catalysts, linkages with other programmes, role of national IPC associations and normative legal actions; (2) To develop guidelines: early planning for their operationalization, initial external technical assistance and local guideline adaption; (3) To establish training: attention to methods, fostering local leadership, and sustainable health system linkages such as developing an IPC career path; (4) To establish health care-associated (HAI) surveillance: feasible but high-impact pilots, multidisciplinary collaboration, mentorship, careful consideration of definitions and data quality, and “data for action”; (5) To implement multimodal strategies: clear communication to explain multimodal strategies, attention to certain elements, and feasible but high-impact pilots; (6) To develop monitoring, audit and feedback: feasible but high-impact pilots, attention to methods such as positive (not punitive) incentives and “data for action”; (7) To improve staffing and bed occupancy: participation of national actors to set standards and attention to methods such as use of data; and (8) To promote built environment: involvement of IPC professionals in facility construction, attention to multimodal strategy elements, and long-term advocacy. Conclusions These IPC implementation themes offer important qualitative evidence for IPC professionals to consider.


Sign in / Sign up

Export Citation Format

Share Document